Skip to main content
CKD Bio Corp. logo

CKD Bio Corp. — Investor Relations & Filings

Ticker · 063160 ISIN · KR7063160006 LEI · 988400RFJ8DLB1NTOE10 KO Manufacturing
Open in API
Filings indexed 146 across all filing types
Latest filing 2021-03-17 Audit Report / Informat…
Country KR South Korea
Listing KO 063160

About CKD Bio Corp.

https://www.ckdbio.com/en/home

CKD Bio Corp. is a pharmaceutical company specializing in fermentation and chemical synthesis technologies. The company develops and manufactures a range of products, including Active Pharmaceutical Ingredients (APIs), intermediates, and probiotics. Its API portfolio features fermentation-based products such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. Leveraging extensive experience in fermentation, CKD Bio also produces next-generation probiotics using patented technology. Additionally, the company provides Contract Manufacturing (CMO) and Contract Research (CRO) services for APIs and intermediates, utilizing its cGMP-certified production facilities.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Chong Kun Dang Bio announcing the submission of an audit report. It provides a summary table of financial data (assets, liabilities, profit/loss) and confirms the audit opinion ('적정' or 'unqualified'). According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full audit report itself, making it a Report Publication Announcement (RPA). FY 2020
2021-03-17 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for (주)종근당바이오. It contains the meeting agenda, date, location, and detailed management information regarding board activities, remuneration, and business outlook (Management Discussion and Analysis). While it contains proxy-like information, it is primarily the official notice and materials for the AGM. According to the provided definitions, documents detailing materials shared for the AGM are classified as AGM-R.
2021-03-11 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal notification filed with the Korea Exchange (KRX) regarding the company's decision to hold its Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the operational reasons for this scheduling and references related disclosures. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2021-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Chong Kun Dang Bio. It outlines the date, location, and agenda items (financial statements, board appointments, remuneration limits) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of the upcoming vote, which falls under the Proxy Solicitation & Information Statement category.
2021-03-05 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Chong Kun Dang Bio regarding the decision to pay cash dividends. It specifies the dividend amount per share, the dividend record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2021-03-05 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Chong Kun Dang Bio) announcing a significant change in financial results (revenue or profit structure change of 30% or more). This is a standard preliminary earnings disclosure required by the Korea Exchange (KRX) for listed companies. Since it provides key financial highlights and preliminary figures before the final audited report, it falls under the 'Earnings Release' category. FY 2020
2021-02-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.